Israel has consented to an arrangement with Moderna Inc for the future acquisition of its potential COVID-19 antibody, Prime Minister Benjamin Netanyahu said on Wednesday.

The Cambridge, Massachusetts-based biotech firm a week ago affirmed intends to begin a preliminary of 30,000 volunteers of its eagerly awaited immunization in July as the organization enters the last phases of testing.

It is one of a few antibodies being tried far and wide as drugmakers race to battle the pandemic. There are as of now no affirmed medicines or immunizations for COVID-19.

"Israel has marked with the organization Moderna a plan that will permit us to purchase immunizations," Netanyahu stated, as indicated by an announcement from his office.

"The organization is propelling its turn of events, they guarantee they can accomplish it by the center of one year from now, we trust that they succeed," he said.

Money related subtleties were not unveiled.

Netanyahu included that Israel would proceed with its own endeavors to build up a COVID-19 antibody through the Israel Institute for Biological Research.

Israel - with a populace of 9 million - has detailed 19,783 novel coronavirus cases and 303 passings. It has seen a spike in new diseases since reviving schools, cafés and numerous organizations a month ago.

Different nations, including France, Germany and Italy, have marked gracefully manages British drugmaker AstraZeneca for its potential COVID-19 immunization.